Crossmark

The use of vitamin D3 sublingual tablets versus oral drops in the treatment of patients with COMT Val/Val genotype and major depressive disorder

Published Online: 2020-03-23

Published Print: 2017-04

Authors

Mech, A.W.
License Information

License valid from 2020-03-23

Text and Data Mining valid from 2017-04-01
More Information

This article is maintained by: Elsevier

Article Title: The use of vitamin D3 sublingual tablets versus oral drops in the treatment of patients with COMT Val/Val genotype and major depressive disorder

Journal Title: European Psychiatry

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eurpsy.2017.01.1334

Content Type: simple-article

Copyright: Copyright © 2017 Published by Elsevier Masson SAS

Document is current